by DiaCarta Inc. | Oct 29, 2018 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta Inc. Launches Ultra-Sensitive TaqMan-Based qPCR Assays for Cancer Gene Mutation Detection FollowFollow DIACARTA Inc., a precision molecular diagnostics company...
by DiaCarta Inc. | Oct 15, 2018 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta, Inc., Awarded $2 Million NCI Contract to Pursue Regulatory Approval of Innovative Cancer Radiation Response Blood Test FollowFollow DIACARTA, Inc., a...
by Wei Liu, Ph.D. | Oct 9, 2018 | Blog
Wei Liu, Ph.D. FollowFollowFollow Common EGFR Mutations in Non-Small Cell Lung CancerEighty five percent of the lung cancer patients are non-small cell lung cancer (NSCLC) patients. Among this population, patients with exon 19 deletion and L858R mutations respond well...
Recent Comments